Search Within

Krisoula Horiates Spatz

Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
  3. Book Section (1)
Groups
  1. Clinical Pharmacy Specialists (8)
  2. Pediatrics, Department of (6)
  3. Neuro-Oncology Service (3)
  4. Orthopaedic Service (3)
  5. Radiology, Department of (3)
  6. Sarcoma Surgeons (3)

More Groups

People
  1. Daniel Prince (3)
  2. Ira Dunkel (3)
  3. Jennifer Thackray (3)
  4. Katarzyna Ibanez (3)
  5. Matthias Karajannis (3)
  6. Sameer Farouk Sait (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2018 (1)
  6. 2017 (2)
Publications
  1. Pediatric Blood and Cancer (3)
  2. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist (1)
  3. JCO Precision Oncology (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Oncology Pharmacy Practice (1)
  6. Neuro-Oncology (1)
Publishers
  1. Wiley Periodicals, Inc (3)
  2. American Society of Clinical Oncology (2)
  3. Oxford University Press (1)
  4. Sage Publications Ltd. (1)
  5. Springer International Publishing (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and tolerability of intravenous aprepitant and fosaprepitant in children with cancer: A retrospective, single-center review
    Journal Article

    Kanukollu, S.; Spatz, K.; Lavery, J. A.; Bender, J. G.; Mauguen, A.; Mathew, S.
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Slipped capital femoral epiphyses: A major on‐target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients
    Journal Article

    Farouk Sait, S.; Fischer, C.; Antal, Z.; Spatz, K.; Prince, D. E.; Ibanez, K.; Behr, G. G.; Dunkel, I. J.; Karajannis, M. A.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Debio1347, an oral FGFR inhibitor: Results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas
    Journal Article

    Sait, S. F.; Gilheeney, S. W.; Bale, T. A.; Haque, S.; Dinkin, M. J.; Vitolano, S.; Rosenblum, M. K.; Ibanez, K.; Prince, D. E.; Spatz, K. H.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas
    Meeting Abstract

    Sait, S. F.; Rosenblum, M.; Bale, T.; Haque, S.; Gilheeney, S.; Spatz, K.; Prince, D.; Ibanez, K.; Dunkel, I.; Karajannis, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Medications commonly used in pediatric HSCT
    Book Section

    Mulieri, K. M.; Teusink-Cross, A.; Weilnau, J.; Spatz, K.; Gatwood, K. S.
    In Brown, V. I. (Eds.) Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist (2018)

    Fulltext@MSK | Save
  • Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Liu, D.; Horiates, K.; Mathew, S.; Pozotrigo, M.; Thackray, J.; Kussin, M.; Yan, S. Q.; Seyboth, B. M.; Modak, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Vincristine toxicity with co-administration of fluconazole: Long-term concerns
    Journal Article

    Thackray, J.; Spatz, K.; Steinherz, P. G.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save